Table 3.
Variable | Cystatin C/creatinine ratio (per 1 increase) |
|||||||
---|---|---|---|---|---|---|---|---|
Unadjusted |
Model 1 |
Model 2 |
Model 3 |
|||||
OR (95% CI) | p-value | aOR (95% CI) | p-value | aOR (95% CI) | p-value | aOR (95% CI) | p-value | |
Sarcopenia | 5.39 (2.53–11.50) | <0.001 | 2.33 (1.06–5.15) | 0.04 | 2.62 (1.13–6.08) | 0.02 | 4.60 (1.67–12.68) | 0.003 |
Low LTI | 10.34 (4.62–23.15) | <0.001 | 4.57 (2.00–10.41) | <0.001 | 4.72 (1.96–11.35) | 0.001 | 7.18 (2.56–20.17) | <0.001 |
Low HGS | 6.92 (3.27–14.65) | <0.001 | 2.11 (0.98–4.56) | 0.06 | 2.02 (0.90–4.53) | 0.09 | 2.59 (1.01–6.64) | 0.048 |
Model 1: adjusted for age and body mass index. Model 2: adjusted for model 1 plus diabetes mellitus and hypertension. Model 3: adjusted for model 2 plus albumin, hemoglobin, and estimated glomerular filtration rate.
aOR, adjusted odds ratio; CI, confidence interval; HGS, handgrip strength; LTI, lean tissue index.